We selected five AML cases with high, intermediate, or low expression of one of the major neutrophil serine proteases, ELANE (Fig. 1 and Supplemental Table S1) and, as a negative control, a human leukemia cell line (K562) that does not express ELANE. This evidence concerns the gene ELANE and acute myeloid leukemia.